Related references
Note: Only part of the references are listed.The Biology of Proteostasis in Aging and Disease
Johnathan Labbadia et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts
Diana Gabriel et al.
AGING CELL (2015)
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
Richard A. Miller et al.
AGING CELL (2014)
Progeria: A Paradigm for Translational Medicine
Leslie B. Gordon et al.
CELL (2014)
Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome
Leslie B. Gordon et al.
CIRCULATION (2014)
53BP1: pro choice in DNA repair
Michal Zimmerman et al.
TRENDS IN CELL BIOLOGY (2014)
Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in Patients With Hutchinson-Gilford Progeria Syndrome
Sophie Blondel et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice
Karl A. Rodriguez et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity
William Dott et al.
REDOX BIOLOGY (2014)
Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
Lan Ye et al.
AGING-US (2013)
Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment
Ricardo Villa-Bellosta et al.
CIRCULATION (2013)
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture
Jose Rivera-Torres et al.
JOURNAL OF PROTEOMICS (2013)
Targeting Isoprenylcysteine Methylation Ameliorates Disease in a Mouse Model of Progeria
Mohamed X. Ibrahim et al.
SCIENCE (2013)
Preserving Youth: Does Rapamycin Deliver?
Simon C. Johnson et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
DNA Base Damage by Reactive Oxygen Species, Oxidizing Agents, and UV Radiation
Jean Cadet et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors
Stephen A. Adam et al.
NUCLEUS (2013)
Rapamycin Allosterically Inhibits the Proteasome
Pawel A. Osmulski et al.
MOLECULAR PHARMACOLOGY (2013)
Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome Implications for normal aging and age-dependent neurodegenerative disorders
John J. Graziotto et al.
AUTOPHAGY (2012)
Homologous recombination and its regulation
Lumir Krejci et al.
NUCLEIC ACIDS RESEARCH (2012)
TOR signaling never gets old: Aging, longevity and TORC1 activity
Daniel S. Evans et al.
AGEING RESEARCH REVIEWS (2011)
The role of nuclear lamin B1 in cell proliferation and senescence
Takeshi Shimi et al.
GENES & DEVELOPMENT (2011)
The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine
Shane A. Richards et al.
HUMAN MOLECULAR GENETICS (2011)
Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect
Valerie L. R. M. Verstraeten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Efficacy and Safety of Sirolimus and Everolimus in Heart Transplant Patients: A Retrospective Analysis
B. Baur et al.
TRANSPLANTATION PROCEEDINGS (2011)
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study
Henrik Ekberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients
Gabriela Viteri et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase Inhibition
Jackleen Marji et al.
PLOS ONE (2010)
Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3
Martin Gamerdinger et al.
EMBO JOURNAL (2009)
Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging
Sofia Rodriguez et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
Aruna D. Balgi et al.
PLOS ONE (2009)
Direct control of mitochondrial function by mTOR
Arvind Ramanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Temsirolimus, an inhibitor of mammalian target of rapamycin
Brian I. Rini
CLINICAL CANCER RESEARCH (2008)
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
Ignacio Varela et al.
NATURE MEDICINE (2008)
The Mutant Form of Lamin A that Causes Hutchinson-Gilford Progeria Is a Biomarker of Cellular Aging in Human Skin
Dayle McClintock et al.
PLOS ONE (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A
Yiyong Liu et al.
JOURNAL OF CELL SCIENCE (2006)
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer
Manuel Hidalgo et al.
CLINICAL CANCER RESEARCH (2006)
Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci
Kaliyaperumal Manju et al.
JOURNAL OF CELL SCIENCE (2006)
Lamin A-dependent nuclear defects in human aging
P Scaffidi et al.
SCIENCE (2006)
A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria
LG Fong et al.
SCIENCE (2006)
Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-lamin A G608G antibody
D McClintock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition
MW Glynn et al.
HUMAN MOLECULAR GENETICS (2005)
Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome
MP Mallampalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome
BC Capell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation
SH Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genomic instability in laminopathy-based premature aging
BH Liu et al.
NATURE MEDICINE (2005)
Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress
M Paradisi et al.
BMC CELL BIOLOGY (2005)
Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome
P Scaffidi et al.
NATURE MEDICINE (2005)
The role of pyocyanin in Pseudomonas aeruginosa infection
GW Lau et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome
RD Goldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lamin A truncation in Hutchinson-Gilford progeria
A De Sandre-Giovannoli et al.
SCIENCE (2003)
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
M Eriksson et al.
NATURE (2003)